who manufactures glp 1 drugs Medicare GLP-1 Drug Coverage GLP-1 Medications for Weight Loss:

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

Lee DSU, Lee H

doi: 10.1111/j.1365-2826.2012.02364.x, 85 LaFataE

Diabetes Care (2024), DOI - doi.org/10.2337/dci24-0003, Written by Vijay Kumar Malesu Vijay holds a Ph.D

However, about 11% of those with T2DM did not respond even to the highest dose of tirzepatide [53-55]

Metformin at $7 per month produces roughly 3% weight loss, or about $2.33 per percentage point